Sézary syndrome: immunocytological and cytochemical variability of Sézary cells. 1980

A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer

The characteristic large cells in the blood of a patient with Sézary syndrome underwent immunocytological and cytochemical changes during polychemotherapy, which caused transient regression of skin lesions. Tartrate-resistant acid phosphatase was demonstrable in a few cells only after chemotherapy; initially, only 2% T cells and 26% B cells could be demonstrated in the blood by immunocytological methods; after cytostatic therapy, 35% T cells but no B cells were detected.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005448 Fluocortolone A glucocorticoid with anti-inflammatory activity used topically for various skin disorders. Fluocortolone Caproate,Fluocortolone Pivalate,Ultralan,Caproate, Fluocortolone,Pivalate, Fluocortolone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000135 Acid Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2. Acid beta-Glycerophosphatase,Acid beta Glycerophosphatase
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012751 Sezary Syndrome A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells). Erythroderma, Sezary,Sezary's Lymphoma,Lymphoma, Sezary's,Sezary Erythroderma,Sezary Lymphoma,Sezarys Lymphoma,Syndrome, Sezary
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
October 1980, Zeitschrift fur Hautkrankheiten,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
July 1976, The British journal of dermatology,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
January 2008, Annales de biologie clinique,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
January 1979, Dermatologica,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
January 1971, Giornale italiano di dermatolotia. Minerva dermatologica,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
January 1980, Sovetskaia meditsina,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
July 1979, Orvosi hetilap,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
November 1975, The British journal of dermatology,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
October 1983, The Journal of investigative dermatology,
A Konrads, and U Laaser, and W Hummerich, and B Mödder, and J Zach, and G R Krueger, and H E Schaefer
August 1978, Haematologica,
Copied contents to your clipboard!